Assessment of a self-deferral form for screening blood donors, Chiang Mai University Hospital, Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 39, Issue 5, 2008, Pages 913-916

  Thaikruea, Lakkana ^a   Nantachit, Niwes ^a   Leetrakool, Nipapan ^a   Fongsatitkul, Ladda ^a   Sompan, Prakai ^a   Heaton, Andrew ^b   Nelson, Kenrad E ^c  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b NOVARTIS PHARMA AG   (Switzerland)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD; BLOOD DONOR; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; ISOLATION AND PURIFICATION; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; QUESTIONNAIRE; SEX DIFFERENCE; SOCIOECONOMICS; SYPHILIS; THAILAND; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BLOOD DONORS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HIV CORE PROTEIN P24; HIV-1; HIV-2; HOSPITALS, UNIVERSITY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; QUESTIONNAIRES; SEX FACTORS; SOCIOECONOMIC FACTORS; SYPHILIS; THAILAND; YOUNG ADULT;

EID: 60249085854     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Apichartpiyakul C, Apichartpiyakul N, Urwijitaroon Y, et al. Seroprevalence and subtype distribution of hepatitis C virus among blood donors and intravenous drug users in northern/northeastern Thailand. Jpn J Infect Dis 1999; 52: 121-3.
2. Brojer E, Grabarczyk P, Liszewski G, et al. Characterization of HBV DNA+/HBsAg-blood donors in Poland identified by Triplex NAT. Hepatology 2006; 44: 1666-74.
3. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-6.
4. Delage G, Infante-Rivard C, Chiavetta JA, Williams B, Pi D, Fast M. Risk factors for acquisition of hepatitis C virus infection in blood donors. Results of a case-control study. Gastroenterology 1999; 116: 893-9.
5. Fong Y-L, Madriaga D, Shyamala V, et al. Evaluation of analytical sensitivity of Chiron target capture HBV DNA assay for HBV detection and quantification and comparison with NGI SuperQuant™ HBV DNA assay. Transfusion 2006; 46: 184.
6. Hakiza SA, Glynn ST, Hutching J, et al. Do blood donors read and understand screening educational materials? Transfusion 2003; 43: 1075-83.
7. Koppelman MH, Assal A, Chudy M, et al. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA and hepatitis B virus DNA in blood donations. Transfusion 2005; 45: 1258-66.
8. Laosombat V, Pornpatkul M, Wongchanchailert M, et al. The prevalence of hepatitis C virus anti-bodies in thalassemic patients in the south of Thailand. Southeast Asian J Trop Med Public Health 1997; 28: 149-53.
9. Mundee Y, Kamtorn N, Chaiyaphruk S, Nantachit N, Ness PM, Nelson KE. Infectious disease markers in blood donors in northern Thailand. Transfusion 1995; 35: 264-7.
10. Murphy EL, Bryzman SM, Glynn SA, et al. Risk factors for hepatitis C virus infection in United States blood donors. Hepatology 2000; 31: 756-62.
11. Nantachit N, Robison V, Wongthanee A, Kamtorn N, Suriyanon V, Nelson KE. Temporal trends in the prevalence of HIV and other transfusion-transmissible infections among blood donors in northern Thailand, 1990 through 2001. Transfusion 2003; 43: 730-5.
12. Nelson KE, Celentano DD, Suprasert S, et al. Risk factors for HIV infection in young men in Northern Thailand. JAMA 1993; 270: 955-60.
13. Schreiber GB, Busch MP, Kleinman SH, et al. The risk of transfusion transmitted viral infections. The Retrovirus Epidemiology Study. N Engl J Med 1996; 334: 1685-90.
14. Sharma UK, Schreiber GB, Glynn SA, et al. The retrovirus epidemiology donor study. Knowledge of HIV/AIDS transmission and screening in United States blood donors. Transfusion 2001; 41: 1341-50.
15. Shyamada V, Arcangel P, Cottrell J, et al. Assessment of target capture PCR hepatitis B virus (HBV) DNA quantitative assay and comparison with commercial HBV DNA quantitative assays. J Clin Microbiol 2004; 42: 5199-204.
16. Terrault N. Sexual activity as a risk factor for hepatitis C. Hepatology 2002; 36: S99-s105.
17. Thaikruea L, Thongsawat S, Netski D, Thomas DL, Nelson KE. Risk factors for hepatitis C virus infection among blood donors in northern Thailand. Transfusion 2004; 44: 1433-40.
18. Van den Burg PJ, Vrielink H, Reesink HW. Donor selection: the exclusion of high risk donors? Vox Sang 1998; 74 (suppl 2): 499-502.
19. Weniger BG, Limjakaragaarat K, Ungchusak K, et al. The epidemiology of HIV infection and AIDS in Thailand. AIDS 1991; 5(suppl 2): S75-S85.